Gene Synthesis Market Size, Share, Trends, Innovations, Outlook 2022-2030

The global Gene Synthesis market size is expected to be worth around US$ 10.58 billion by 2030, according to a new report by Vision Research Reports.

The global Gene Synthesis market size was valued at US$ 2.47 billion in 2020 and is anticipated to grow at a CAGR of 19.1% during forecast period 2021 to 2030.

Download Exclusive Sample of Report@ https://www.visionresearchreports.com/report/sample/39078

Report Coverage

Report Scope Details
Market Size US$ 10.58 billion by 2030
Growth Rate CAGR of 19.1% From 2021 to 2030
Largest Market North America
Base Year 2021
Forecast Period 2021 to 2030
Segments Covered Method, Service, Application, End use
Regional Scope North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Companies Mentioned GenScript; GENEWIZ; Boster Biological Technology; Twist Bioscience; ProteoGenix; Biomatik; ProMab Biotechnologies, Inc.; Thermo Fisher Scientific, Inc.; Integrated DNA Technologies, Inc.; OriGene Technologies, Inc.

Growth Factors

Gene synthesis space is offering enormous potential for new biological functionality. This has resulted in the introduction of supportive government policies associated with synthetic biology, thereby driving the market.

Industry participants strive for developing proprietary and new technologies to strengthen their market presence. Furthermore, the establishment of organizations and forums helps encourage researchers to opt and study genetic engineering-related concepts and develop innovative technologies, which is also a notable growth driver of this space.

Considering this space as a lucrative source of revenue, companies are focusing on collaborations with various universities for on-site training, online workshops, and sponsored projects to boost their expertise portfolio. This is also expected to generate interest among research professionals by helping them realize the potential of this field and therefore spurring adoption in the market.

By Method Analysis

The solid-phase synthesis segment captured the maximum revenue share of more than 36% in 2020 owing to the highest adoption rate over the past few years. Also, the high accuracy of this method further boosts its deployment among the therapy developers and research settings.

PCR- and chip-based methods are anticipated to register significant CAGRs over the forecast period. These methods allow the synthesis of larger fragments at a lower rate, resulting in their increased usage.

By Service Analysis

The antibody DNA synthesis segment led the market with a revenue share of more than 60% in 2020. The presence of a substantial number of market players offering services for antibody DNA synthesis has resulted in the dominance of this segment.

Companies are offering services to pharma/biotech companies and research institutions to allow cloning and synthesis of antibody heavy/light chain sequences into any custom vector. On the other hand, the viral gene synthesis segment is estimated to register the fastest CAGR from 2021 to 2028 owing to the increasing virus vector-related R&D activities.

Companies are engaged in the synthesis of all non-structural and structural protein genes or gene fragments of the SARS-CoV-2. This has accelerated the acquisition of the virus recombinant proteins and has encouraged the research of protein structural biology of the virus particles.

By Application Analysis

The gene & cell therapy development segment accounted for the largest revenue share of more than 35% in 2020. This is anticipated to continue expanding the pipeline of advanced therapies for treating chronic conditions.

Academic institutions and companies across the globe are actively engaged in the development of new therapies, which are likely to boost the demand for services in this market.

the companies are also focusing on investments and funding to extend their capabilities for stem cell therapies and regenerative medicines. On the other hand, the vaccine development segment is anticipated to witness the fastest CAGR from 2021 to 2028 due to the rising concerns regarding future pandemics.

By End-use Analysis

The academic and government research institutes segment dominated the global market in 2020 accounting for a revenue share of over 54%. The segment is estimated to expand further at the fastest CAGR from 2021 to 2028 owing to the high usage of gene synthesis services in research settings.

The biotechnology & pharmaceutical companies segment is anticipated to witness notable growth during the forecast period. Increasing usage of synthesis biology by biotech companies for the development of novel disease management modalities is expected to bolster the segment growth.

By Regional Analysis

North America accounted for the largest revenue share of more than 38% in 2020 due to the presence of major players and supportive government initiatives pertaining to the training and implementation of synthetic biology programs.

Asia Pacific is estimated to register the fastest CAGR from 2021 to 2028. This can be attributed to the rising investments by global companies in the regional market. Moreover, the presence of some key companies in emerging nations, such as China and India, contributes to the market growth.

Key Players

  • GenScript
  • Brooks Automation, Inc. (GENEWIZ)
  • Boster Biological Technology
  • Twist Bioscience
  • ProteoGenix
  • Biomatik
  • ProMab Biotechnologies, Inc.
  • Thermo Fisher Scientific, Inc.
  • Integrated DNA Technologies, Inc.
  • OriGene Technologies, Inc.

Market Segmentation

  • By Method
    • Solid-phase Synthesis
    • Chip-based Synthesis
    • PCR-based Enzyme Synthesis
  • By Service
    • Antibody DNA Synthesis
    • Viral DNA Synthesis
    • Others
  • By Application
    • Gene & Cell Therapy Development
    • Vaccine Development
    • Disease Diagnosis
    • Others
  • By End-use
    • Biotechnology & Pharmaceutical Companies
    • Academic & Government Research Institutes
    • Contract Research Organizations
  • Regional
    • North America
      • U.S.
      • Canada
    • Europe
      • Germany
      • France
      • U.K.
      • Italy
      • Spain
    • Asia Pacific
      • Japan
      • China
      • South Korea
      • India
    • Latin America
      • Brazil
      • Mexico
    • Middle East and Africa (MEA)
      • South Africa
      • Saudi Arabia

Buy this Research Report study@ https://www.visionresearchreports.com/report/cart/39078

Reasons to Purchase this Report:

– Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
– Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
– Market value USD Million and volume Units Million data for each segment and sub-segment
– Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
– Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players

Table of Contents

Chapter 1.  Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.  Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.  Executive Summary

3.1.  Market Snapshot

Chapter 4.  Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.    Raw Material Procurement Analysis

4.3.2.    Sales and Application Analysis

4.3.3.    Downstream Buyer Analysis

Chapter 5.  Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.    Market Drivers

5.1.2.    Market Restraints

5.1.3.    Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.    Bargaining power of suppliers

5.2.2.    Bargaining power of buyers

5.2.3.    Threat of substitute

5.2.4.    Threat of new entrants

5.2.5.    Degree of competition

Chapter 6.  Competitive Landscape

6.1.1.    Company Market Share/Positioning Analysis

6.1.2.    Key Strategies Adopted by Players

6.1.3.    Vendor Landscape

6.1.3.1.        List of Suppliers

6.1.3.2.        List of Buyers

Chapter 7.  Global Gene Synthesis Market, By Method

7.1.  Gene Synthesis Market, by Method, 2021-2030

7.1.1.    Solid-phase Synthesis

7.1.1.1.        Market Revenue and Forecast (2017-2030)

7.1.2.    Chip-based Synthesis

7.1.2.1.        Market Revenue and Forecast (2017-2030)

7.1.3.    PCR-based Enzyme Synthesis

7.1.3.1.        Market Revenue and Forecast (2017-2030)

Chapter 8.  Global Gene Synthesis Market, By Service

8.1.  Gene Synthesis Market, by Service, 2021-2030

8.1.1.    Antibody DNA Synthesis

8.1.1.1.        Market Revenue and Forecast (2017-2030)

8.1.2.    Viral DNA Synthesis

8.1.2.1.        Market Revenue and Forecast (2017-2030)

Chapter 9.  Global Gene Synthesis Market, By Application

9.1.  Gene Synthesis Market, by Application, 2021-2030

9.1.1.    Gene & Cell Therapy Development

9.1.1.1.        Market Revenue and Forecast (2017-2030)

9.1.2.    Vaccine Development

9.1.2.1.        Market Revenue and Forecast (2017-2030)

9.1.3.    Disease Diagnosis

9.1.3.1.        Market Revenue and Forecast (2017-2030)

Chapter 10.      Global Gene Synthesis Market, By End-use

10.1.        Gene Synthesis Market, by End-use, 2021-2030

10.1.1.  Biotechnology & Pharmaceutical Companies

10.1.1.1.      Market Revenue and Forecast (2017-2030)

10.1.2.  Academic & Government Research Institutes

10.1.2.1.      Market Revenue and Forecast (2017-2030)

10.1.3.  Contract Research Organizations

10.1.3.1.      Market Revenue and Forecast (2017-2030)

Chapter 11.      Global Gene Synthesis Market, Regional Estimates and Trend Forecast

11.1.        North America

11.1.1.  Market Revenue and Forecast, by Method (2017-2030)

11.1.2.  Market Revenue and Forecast, by Service (2017-2030)

11.1.3.  Market Revenue and Forecast, by Application (2017-2030)

11.1.4.  Market Revenue and Forecast, by End-use (2017-2030)

11.1.5.  U.S.

11.1.5.1.      Market Revenue and Forecast, by Method (2017-2030)

11.1.5.2.      Market Revenue and Forecast, by Service (2017-2030)

11.1.5.3.      Market Revenue and Forecast, by Application (2017-2030)

11.1.5.4.      Market Revenue and Forecast, by End-use (2017-2030)

11.1.6.  Rest of North America

11.1.6.1.      Market Revenue and Forecast, by Method (2017-2030)

11.1.6.2.      Market Revenue and Forecast, by Service (2017-2030)

11.1.6.3.      Market Revenue and Forecast, by Application (2017-2030)

11.1.6.4.      Market Revenue and Forecast, by End-use (2017-2030)

11.2.        Europe

11.2.1.  Market Revenue and Forecast, by Method (2017-2030)

11.2.2.  Market Revenue and Forecast, by Service (2017-2030)

11.2.3.  Market Revenue and Forecast, by Application (2017-2030)

11.2.4.  Market Revenue and Forecast, by End-use (2017-2030)

11.2.5.  UK

11.2.5.1.      Market Revenue and Forecast, by Method (2017-2030)

11.2.5.2.      Market Revenue and Forecast, by Service (2017-2030)

11.2.5.3.      Market Revenue and Forecast, by Application (2017-2030)

11.2.5.4.      Market Revenue and Forecast, by End-use (2017-2030)

11.2.6.  Germany

11.2.6.1.      Market Revenue and Forecast, by Method (2017-2030)

11.2.6.2.      Market Revenue and Forecast, by Service (2017-2030)

11.2.6.3.      Market Revenue and Forecast, by Application (2017-2030)

11.2.6.4.      Market Revenue and Forecast, by End-use (2017-2030)

11.2.7.  France

11.2.7.1.      Market Revenue and Forecast, by Method (2017-2030)

11.2.7.2.      Market Revenue and Forecast, by Service (2017-2030)

11.2.7.3.      Market Revenue and Forecast, by Application (2017-2030)

11.2.7.4.      Market Revenue and Forecast, by End-use (2017-2030)

11.2.8.  Rest of Europe

11.2.8.1.      Market Revenue and Forecast, by Method (2017-2030)

11.2.8.2.      Market Revenue and Forecast, by Service (2017-2030)

11.2.8.3.      Market Revenue and Forecast, by Application (2017-2030)

11.2.8.4.      Market Revenue and Forecast, by End-use (2017-2030)

11.3.        APAC

11.3.1.  Market Revenue and Forecast, by Method (2017-2030)

11.3.2.  Market Revenue and Forecast, by Service (2017-2030)

11.3.3.  Market Revenue and Forecast, by Application (2017-2030)

11.3.4.  Market Revenue and Forecast, by End-use (2017-2030)

11.3.5.  India

11.3.5.1.      Market Revenue and Forecast, by Method (2017-2030)

11.3.5.2.      Market Revenue and Forecast, by Service (2017-2030)

11.3.5.3.      Market Revenue and Forecast, by Application (2017-2030)

11.3.5.4.      Market Revenue and Forecast, by End-use (2017-2030)

11.3.6.  China

11.3.6.1.      Market Revenue and Forecast, by Method (2017-2030)

11.3.6.2.      Market Revenue and Forecast, by Service (2017-2030)

11.3.6.3.      Market Revenue and Forecast, by Application (2017-2030)

11.3.6.4.      Market Revenue and Forecast, by End-use (2017-2030)

11.3.7.  Japan

11.3.7.1.      Market Revenue and Forecast, by Method (2017-2030)

11.3.7.2.      Market Revenue and Forecast, by Service (2017-2030)

11.3.7.3.      Market Revenue and Forecast, by Application (2017-2030)

11.3.7.4.      Market Revenue and Forecast, by End-use (2017-2030)

11.3.8.  Rest of APAC

11.3.8.1.      Market Revenue and Forecast, by Method (2017-2030)

11.3.8.2.      Market Revenue and Forecast, by Service (2017-2030)

11.3.8.3.      Market Revenue and Forecast, by Application (2017-2030)

11.3.8.4.      Market Revenue and Forecast, by End-use (2017-2030)

11.4.        MEA

11.4.1.  Market Revenue and Forecast, by Method (2017-2030)

11.4.2.  Market Revenue and Forecast, by Service (2017-2030)

11.4.3.  Market Revenue and Forecast, by Application (2017-2030)

11.4.4.  Market Revenue and Forecast, by End-use (2017-2030)

11.4.5.  GCC

11.4.5.1.      Market Revenue and Forecast, by Method (2017-2030)

11.4.5.2.      Market Revenue and Forecast, by Service (2017-2030)

11.4.5.3.      Market Revenue and Forecast, by Application (2017-2030)

11.4.5.4.      Market Revenue and Forecast, by End-use (2017-2030)

11.4.6.  North Africa

11.4.6.1.      Market Revenue and Forecast, by Method (2017-2030)

11.4.6.2.      Market Revenue and Forecast, by Service (2017-2030)

11.4.6.3.      Market Revenue and Forecast, by Application (2017-2030)

11.4.6.4.      Market Revenue and Forecast, by End-use (2017-2030)

11.4.7.  South Africa

11.4.7.1.      Market Revenue and Forecast, by Method (2017-2030)

11.4.7.2.      Market Revenue and Forecast, by Service (2017-2030)

11.4.7.3.      Market Revenue and Forecast, by Application (2017-2030)

11.4.7.4.      Market Revenue and Forecast, by End-use (2017-2030)

11.4.8.  Rest of MEA

11.4.8.1.      Market Revenue and Forecast, by Method (2017-2030)

11.4.8.2.      Market Revenue and Forecast, by Service (2017-2030)

11.4.8.3.      Market Revenue and Forecast, by Application (2017-2030)

11.4.8.4.      Market Revenue and Forecast, by End-use (2017-2030)

11.5.        Latin America

11.5.1.  Market Revenue and Forecast, by Method (2017-2030)

11.5.2.  Market Revenue and Forecast, by Service (2017-2030)

11.5.3.  Market Revenue and Forecast, by Application (2017-2030)

11.5.4.  Market Revenue and Forecast, by End-use (2017-2030)

11.5.5.  Brazil

11.5.5.1.      Market Revenue and Forecast, by Method (2017-2030)

11.5.5.2.      Market Revenue and Forecast, by Service (2017-2030)

11.5.5.3.      Market Revenue and Forecast, by Application (2017-2030)

11.5.5.4.      Market Revenue and Forecast, by End-use (2017-2030)

11.5.6.  Rest of LATAM

11.5.6.1.      Market Revenue and Forecast, by Method (2017-2030)

11.5.6.2.      Market Revenue and Forecast, by Service (2017-2030)

11.5.6.3.      Market Revenue and Forecast, by Application (2017-2030)

11.5.6.4.      Market Revenue and Forecast, by End-use (2017-2030)

Chapter 12.  Company Profiles

12.1.              GenScript

12.1.1.  Company Overview

12.1.2.  Method Offerings

12.1.3.  Financial Performance

12.1.4.  Recent Initiatives

12.2.              Brooks Automation, Inc. (GENEWIZ)

12.2.1.  Company Overview

12.2.2.  Method Offerings

12.2.3.  Financial Performance

12.2.4.  Recent Initiatives

12.3.              Boster Biological Technology

12.3.1.  Company Overview

12.3.2.  Method Offerings

12.3.3.  Financial Performance

12.3.4.  Recent Initiatives

12.4.              Twist Bioscience

12.4.1.  Company Overview

12.4.2.  Method Offerings

12.4.3.  Financial Performance

12.4.4.  Recent Initiatives

12.5.              ProteoGenix

12.5.1.  Company Overview

12.5.2.  Method Offerings

12.5.3.  Financial Performance

12.5.4.  Recent Initiatives

12.6.              Biomatik

12.6.1.  Company Overview

12.6.2.  Method Offerings

12.6.3.  Financial Performance

12.6.4.  Recent Initiatives

12.7.              ProMab Biotechnologies, Inc.

12.7.1.  Company Overview

12.7.2.  Method Offerings

12.7.3.  Financial Performance

12.7.4.  Recent Initiatives

12.8.              Thermo Fisher Scientific, Inc.

12.8.1.  Company Overview

12.8.2.  Method Offerings

12.8.3.  Financial Performance

12.8.4.  Recent Initiatives

12.9.              Integrated DNA Technologies, Inc

12.9.1.  Company Overview

12.9.2.  Method Offerings

12.9.3.  Financial Performance

12.9.4.  Recent Initiatives

12.10.           OriGene Technologies, Inc.

12.10.1.               Company Overview

12.10.2.               Method Offerings

12.10.3.               Financial Performance

12.10.4.               Recent Initiatives

Chapter 13.  Research Methodology

13.1.              Primary Research

13.2.              Secondary Research

13.3.              Assumptions

Chapter 14.  Appendix

14.1.              About Us

Glossary of Terms

Buy this Research Report study@ https://www.visionresearchreports.com/report/cart/39078

Contact Us:

Vision Research Reports

Call: +1 9197 992 333

Email: sales@visionresearchreports.com